Results 41 to 50 of about 2,819,480 (307)

Strength through diversity: how cancers thrive when clones cooperate

open access: yesMolecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken   +3 more
wiley   +1 more source

PENERAPAN TARGET COSTING DALAM PENGENDALIAN BIAYA PRODUKSI (Studi pada PT. Citra Prima Selaras Lamongan) [PDF]

open access: yes, 2007
PT. Citra Prima Selaras is a company engaged in the business of real estate, shop, and general trading. Writing is a case study on PT. Citra Prima Lamongan Consistent with the title "Application of Target Costing In Control Production Costs." Target ...
Ningsih, Yuliani
core  

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Sustainability of bread from ancient wheat: environmental impact and economic assessment in organic and conventional supply chains

open access: yesActa Agriculturae Scandinavica. Section B, Soil and Plant Science
This study assesses the environmental and economic sustainability of bread production chain using an ancient soft wheat (var. Verna), cultivated under conventional and organic farming systems. A Life Cycle Assessment from wheat cultivation through baking
L. Verdi   +5 more
doaj   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

ANALISIS PROFITABILITAS USAHATANI CABAI MERAH (Capsicum annuum) DI DESA GOMBONG KECAMATAN BELIK KABUPATEN PEMALANG

open access: yesAgritech, 2016
The study aimed to determine the profitability of red chili farming (Capsicum annuum) in Gombong village, Belik District, Pemalang. The study applied purposive sampling method on 60 samples of red chili farmers.
Wiit Rismawanto   +2 more
doaj  

Honey Cost: An Experimental Approach for Determining the Production Costs of Honey

open access: yesProceedings
The Honey Cost project, conceived and developed by the CREA Policies and Bioeconomics research center (CREA PB), will develop a methodology and tools for ad hoc data collection and evaluation of the bee and honey sector and sets up a sample survey on it.
Concetta Cardillo   +2 more
doaj   +1 more source

Cost and productivity [PDF]

open access: yesManagerial and Decision Economics, 2000
We develop an analytical model capable of decomposing both intertemporal and multilateral cost variation. We begin by attributing cost variation to a price effect and a quantity effect. We then decompose the quantity effect into a productivity effect and an activity effect.
Grifell-Tatjé, Emili   +1 more
openaire   +2 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy